Reduced Glutathione Peroxidase (GPx) Activity in Patients with Cutaneous Leishmaniasis
Comprehensive Health and Biomedical Studies · 2024
DOI: 10.5812/chbs-147175 ↗Kurz gefasst
Fachartikel in der Zeitschrift Comprehensive Health and Biomedical Studies, 2024. Verfasst von Marziye Pashmforosh und 4 weiteren Autor:innen. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Cutaneous leishmaniasis (CL) is a tropical parasitic infection that involves several factors in its pathogenesis, including oxidative stress. The oxidative stress in CL may deplete antioxidant nutrients.
Objectives
The aim of the study was to measure glutathione peroxidase (GPx) activity in patients with CL.
Methods
The investigation included 80 patients with CL and 80 healthy participants. A diagnostic kit was used to measure GPx activity.
Results
The results showed a significant decrease in GPx activity in the CL patient group compared to the control group (P < 0.001), which is related to increased oxidative stress in patients.
Conclusions
According to the results, GPx enzyme activity can serve as a biomarker for the diagnosis, prognosis, and monitoring of treatment in patients with CL.
Zitieren
APA
Pashmforosh, M., Foroutan, M., Soltani, S., Kahvaz, M. S., & Sabaghan, M. (2024). Reduced Glutathione Peroxidase (GPx) Activity in Patients with Cutaneous Leishmaniasis. Comprehensive Health and Biomedical Studies. https://doi.org/10.5812/chbs-147175
Vancouver
Pashmforosh M, Foroutan M, Soltani S, Kahvaz MS, Sabaghan M. Reduced Glutathione Peroxidase (GPx) Activity in Patients with Cutaneous Leishmaniasis. Comprehensive Health and Biomedical Studies. 2024. doi:10.5812/chbs-147175
BibTeX
@article{Pashmforosh2024,
author = {Pashmforosh, Marziye and Foroutan, Masoud and Soltani, Shahrzad and Kahvaz, Mehdi Sagha and Sabaghan, Mohamad},
title = {Reduced Glutathione Peroxidase (GPx) Activity in Patients with Cutaneous Leishmaniasis},
journal = {Comprehensive Health and Biomedical Studies},
year = {2024},
doi = {10.5812/chbs-147175}
}
EUVIMED